ATE199394T1 - Gag-env fusion-antigen aus hiv - Google Patents

Gag-env fusion-antigen aus hiv

Info

Publication number
ATE199394T1
ATE199394T1 AT92311006T AT92311006T ATE199394T1 AT E199394 T1 ATE199394 T1 AT E199394T1 AT 92311006 T AT92311006 T AT 92311006T AT 92311006 T AT92311006 T AT 92311006T AT E199394 T1 ATE199394 T1 AT E199394T1
Authority
AT
Austria
Prior art keywords
gag
env
hiv antigen
hiv
peptide
Prior art date
Application number
AT92311006T
Other languages
English (en)
Inventor
Atsushi Saito
Hideo Sinagawa
Atsuo Nakata
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Application granted granted Critical
Publication of ATE199394T1 publication Critical patent/ATE199394T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92311006T 1992-06-04 1992-12-02 Gag-env fusion-antigen aus hiv ATE199394T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17027092 1992-06-04

Publications (1)

Publication Number Publication Date
ATE199394T1 true ATE199394T1 (de) 2001-03-15

Family

ID=15901829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92311006T ATE199394T1 (de) 1992-06-04 1992-12-02 Gag-env fusion-antigen aus hiv

Country Status (8)

Country Link
US (2) US5576421A (de)
EP (1) EP0572737B1 (de)
KR (1) KR0143977B1 (de)
CN (1) CN1079509A (de)
AT (1) ATE199394T1 (de)
BR (1) BR9204851A (de)
CA (1) CA2084386C (de)
DE (1) DE69231705T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2178635C (en) * 1993-12-10 2004-05-25 Yu-Wen Hu Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
DE4411718A1 (de) * 1994-04-05 1995-10-12 Gsf Forschungszentrum Umwelt RFB-Retrovirusgenom
US6525173B1 (en) * 1997-01-02 2003-02-25 Universidade Federal De Minas Gerais Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)
WO1998043669A1 (en) * 1997-04-03 1998-10-08 Thomas Jefferson University Chimeric viral proteins
AU784679B2 (en) * 1999-12-23 2006-05-25 International Aids Vaccine Initiative Improvements in or relating to immune responses to HIV
EP2292772A1 (de) * 2001-07-05 2011-03-09 Novartis Vaccines and Diagnostics, Inc. HIV Impfung mit für ein HIV Polypeptid kodierender DNS und einem HIV Polypeptid
US20050112139A1 (en) * 2003-10-23 2005-05-26 Nmk Research, Llc Immunogenic composition and method of developing a vaccine based on factor H binding sites
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2309269B1 (de) 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion
KR101138930B1 (ko) * 2007-02-16 2012-04-25 (주) 에빅스젠 Ｈⅰｖ ｎｃ 단백질을 포함하는 ａⅰｄｓ 예방 및 치료용조성물
CN101475642B (zh) * 2008-11-07 2013-06-05 深圳市菲鹏生物股份有限公司 一种艾滋病毒重组抗原及其融合蛋白
KR102079761B1 (ko) * 2018-05-14 2020-02-20 서울대학교산학협력단 pMyong2 벡터 시스템을 이용하여 HIV-1 p24를 발현하는 재조합 BCG 및 이의 HIV-1 백신으로의 이용

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227169B1 (de) * 1985-12-17 1993-03-17 Akzo N.V. Immunochemisches Reagenz
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
ES2051859T3 (es) * 1987-09-04 1994-07-01 Int Murex Tech Corp Inmunoensayo en fase solida para un anticuerpo y estructuras biologicas para uso en el mismo.
JPH01179687A (ja) * 1987-12-30 1989-07-17 Chemo Sero Therapeut Res Inst Ｈｉｖ融合蛋白質
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
ATE110112T1 (de) * 1988-05-06 1994-09-15 Ferropas Ag Verfahren und systeme zur herstellung von hiv- antigenen.
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
CA2016897A1 (en) 1989-05-17 1990-11-17 John W. Wills Retrovirus-mediated secretion of recombinant products
EP0449116B2 (de) * 1990-03-21 2004-08-25 Geneart GmbH Für abgeänderte retrovirale GAG-Polypeptide kodierende DNA-Sequenzen und diese enthaltende Impfstoffe oder Aggregate davon

Also Published As

Publication number Publication date
KR0143977B1 (ko) 1998-07-15
DE69231705T2 (de) 2001-10-18
DE69231705D1 (de) 2001-04-05
EP0572737B1 (de) 2001-02-28
US5834267A (en) 1998-11-10
KR940000117A (ko) 1994-01-03
EP0572737A3 (de) 1994-11-23
EP0572737A2 (de) 1993-12-08
US5576421A (en) 1996-11-19
CN1079509A (zh) 1993-12-15
CA2084386A1 (en) 1993-12-05
BR9204851A (pt) 1994-06-07
CA2084386C (en) 2001-02-20

Similar Documents

Publication Publication Date Title
AU591054B2 (en) Pre-S gene coded peptide hepatitis B immunogens, vaccines and diagnostics
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
ATE199394T1 (de) Gag-env fusion-antigen aus hiv
GR3031817T3 (en) DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof.
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
EP0298633A2 (de) Synthetische Polypeptide
AU630861B2 (en) Recombinant hiv-2 polypeptides
RU96108781A (ru) Пептиды, создающие нейтрализующие антитела к генетически дифергентным штаммам вич-1
ES2156902T3 (es) Peptidos que inducen la produccion de anticuerpos neutralizantes contra cepas de vih-1 geneticamente divergentes.
KR920002629A (ko) B형 간염 코어 항원의 아미노산 잔기 서열
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
GR3023070T3 (en) NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
AU6393990A (en) Hiv related peptides
TH13136A (th) แอนติเจนของ hiv
KR920703102A (ko) 인간 면역결핍 바이러스(human immunodeficiency virus)에 대한 항체와 선택적으로 반응하는 폴리펩타이드 및 그를 함유하는 백신(vaccines)
DK362088A (da) Fusionsproteiner og fusionsproteinpartikler
CA2085084A1 (en) Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope
GR1000021B (el) Αντιπροσωπευτικο προιον ανοσιογενους ανασυνδυαζομενης ζυμης & μεθοδος καθαρισμου της.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties